L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 45,600 shares at $22.76 ($1.0M) on 2017-08-23, disclosed to the SEC on 2017-08-25.
Open-market sale of $1.0M RVNC by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.76 | 22,800 | $519K | 50.0% |
| 2 | $22.76 | 22,800 | $519K | 50.0% |
| Total | $22.76 avg | 45,600 | $1.0M | 100% |
| Filing → |
| RVNC | SELL | 2018-03-16 | $376K | — | Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |